Vaxil Bio Ltd. reported earnings results for the full year ended December 31, 2022. For the full year, the company reported net loss was CAD 0.584 million compared to CAD 0.986 million a year ago. Basic loss per share from continuing operations was CAD 0.01 compared to CAD 0.01 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 CAD | +50.00% | 0.00% | -40.00% |
1st Jan change | Capi. | |
---|---|---|
-40.00% | 1.5M | |
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.74B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |
- Stock Market
- Equities
- VXL Stock
- News Vaxil Bio Ltd.
- Vaxil Bio Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022